FindTrial
Sign In

The role and mechanism of LDLR in the occurrence and development of AML

The role and mechanism of LDLR in the occurrence and development of AML

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500114283
Enrollment
Unknown
Registered
2025-12-10
Start date
2024-11-30
Completion date
Unknown
Last updated
2025-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute myeloid leukemia

Interventions

Acute myeloid Leukemia Observation Group:None

Sponsors

The Affiliated Yongchuan Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Newly diagnosed cases; 2. Confirmed diagnosis by Department of Hematology, Yongchuan Hospital Affiliated to Chongqing Medical University;

Exclusion criteria

Exclusion criteria: 1. Secondary cases; 2. Recurrent patients; 3. Patients who have received drug chemotherapy or radiation therapy.

Design outcomes

Primary

MeasureTime frame
Low density lipoprotein receptor;—

Countries

China

Contacts

Public ContactLiu Beizhong;Liu Liran

The Affiliated Yongchuan Hospital of Chongqing Medical University

lbz2753@qq.com+86 23 8538 1906

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026